Boosting Population Quits Through Evidence-Based Cessation Treatment and Policy

American Journal of Preventive Medicine

Volumn 38, Issue 3 SUPPL. 1, 2010, Pages

  Abrams, David B ^a   Graham, Amanda L ^a   Levy, David T ^b   Mabry, Patricia L ^c   Orleans, C Tracy ^d  

^a American Legacy Foundation   (United States)

^b UNIVERSITY OF BALTIMORE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d ROBERT WOOD JOHNSON FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONIDINE; NICOTINE GUM; NICOTINE PATCH; NORTRIPTYLINE; NOSE SPRAY; VARENICLINE;

ARTICLE; BEHAVIOR THERAPY; CLINICAL PRACTICE; COMPUTER SIMULATION; FUNDING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROMOTION; HUMAN; INTERNET; MEDICAID; MEDICAL LITERATURE; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; REIMBURSEMENT; SMOKING; SMOKING CESSATION; TELEPHONE; TOBACCO DEPENDENCE; UNITED STATES;

DELIVERY OF HEALTH CARE; DIRECTIVE COUNSELING; EVIDENCE-BASED PRACTICE; HUMANS; INTERNET; POLICY MAKING; PROGRAM EVALUATION; SMOKING; SMOKING CESSATION; TELEPHONE; UNITED STATES;

EID: 76749131504     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2009.12.011     Document Type: Article

References (97)

1. Levy D.T., Cummings K.M., and Hyland A. A simulation of the effects of youth initiation policies overall cigarette use. Am J Public Health 90 8 (2000) 1311-1314
2. CDC. Cigarette smoking among adults-U.S., 2000. MMWR Morb Mortal Wkly Rep 51 29 (2002) 642-645
3. CDC. Cigarette smoking among adults-U.S., 2006. MMWR Morb Mortal Wkly Rep 56 44 (2007) 1157-1161
4. CDC. Annual smoking-attributable mortality, years of potential life lost, and productivity losses-U.S., 1997-2001. MMWR Morb Mortal Wkly Rep 54 25 (2005) 625-628
5. CDC. Tobacco use among adults-U.S., 2005. MMWR Morb Mortal Wkly Rep 55 42 (2006) 1145-1148
6. Fiore M., Jaén C., Baker T., et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline (2008), USDHHS, Public Health Service, Rockville MD
7. Maciosek M.V., Coffield A.B., Edwards N.M., Flottemesch T.J., Goodman M.J., and Solberg L.I. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 31 1 (2006) 52-61
8. IOM. Priority areas for national action: transforming health care quality (2003), National Academies Press, Washington
9. Cokkinides V.E., Ward E., Jemal A., and Thun M.J. Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med 28 1 (2005) 119-122
10. Shiffman S., Brockwell S.E., Pillitteri J.L., and Gitchell J.G. Use of smoking-cessation treatments in the U.S. Am J Prev Med 34 2 (2008) 102-111
11. Orleans C.T. Increasing the demand for and use of effective smoking-cessation treatments reaping the full health benefits of tobacco-control science and policy gains-in our lifetime. Am J Prev Med 33 6S (2007) S340-S348
12. Gollust S., Schroeder S., and Warner K. Helping smokers quit: understanding the barriers to utilization of smoking cessation services. Millbank Q 86 4 (2008) 601-627
13. Backinger C.L., and O'Connell M.E. Developing consensus on tobacco control and research. Am J Prev Med 33 6S (2007) S311-S313
14. National Tobacco Cessation Collaborative. Innovations in building consumer demand for tobacco cessation products and services (2007), Academy for Educational Development, Washington
15. IOM. Ending the tobacco problem: a blueprint for the nation (2007), The National Academies Press, Washington
16. Abrams D. Comprehensive smoking cessation policy for all smokers: systems integration to save lives and money. In: Bonnie R.J., Stratton K., and Wallace R.B. (Eds). Ending the tobacco problem: a blueprint for the nation (2007), The National Academies Press, Washington
17. Levy D.T., Mabry P.L., Graham A.L., Abrams D.B., and Orleans C.T. Modeling the impact of smoking cessation treatment policies on quit rates. Am J Prev Med 38 3S (2010) S364-S372
18. Levy D.T., Mabry P.L., Graham A.L., Orleans C.T., and Abrams D.B. Reaching Healthy People 2010 by 2013: a SimSmoke simulation. Am J Prev Med 38 3S (2010) S373-S381
19. Levy D.T., Nikolayev N., and Mumford E.A. The Healthy People 2010 Smoking Prevalence and Tobacco Control Objectives: results from the SimSmoke Tobacco Control Policy Simulation Model. Cancer Causes Control 16 4 (2005) 359-371
20. Levy D.T., Bauer J.E., and Lee H.R. Simulation modeling and tobacco control: creating more robust public health policies. Am J Public Health 96 3 (2006) 494-498
21. Levy D.T., and Friend K. A simulation model of policies directed at treating tobacco use and dependence. Med Decis Making 22 1 (2002) 6-17
22. Levy D.T., and Friend K. Examining the effects of tobacco treatment policies on smoking rates and smoking-related deaths using the SimSmoke computer simulation model. Tob Control 11 1 (2002) 47-54
23. Burns D., Anderson C., Johnson M., et al. Cessation and cessation measures among daily adult smokers: national- and statespecifi{dotless}c data. Population based smoking cessation: proceedings of a conference on what works to influence cessation in the general population. Smoking and Tobacco Control Monograph No. 12 (November 2000), US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda MD National Cancer Institute. NIH Pub. No. 00-4892
24. Hughes J.R., Benowitz N., Hatsukami D., Mermelstein R.J., and Shiffman S. Clarification of SRNT workgroup guidelines for measures in clinical trials of smoking cessation therapies. Nicotine Tob Res 6 5 (2004) 863-864
25. Hollis J.F., McAfee T.A., Fellows J.L., Zbikowski S.M., Stark M., and Riedlinger K. The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control 16 1S (2007) i53-i59
26. Tinkelman D., Wilson S.M., Willett J., and Sweeney C.T. Offering free NRT through a tobacco quitline: impact on utilisation and quit rates. Tob Control 16 1S (2007) i42-i46
27. An L.C., Schillo B.A., Kavanaugh A.M., et al. Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy. Tob Control 15 4 (2006) 286-293
28. Fellows J.L., Bush T., McAfee T., and Dickerson J. Cost effectiveness of the Oregon quitline "free patch initiative.". Tob Control 16 1S (2007) i47-i52
29. Metzger K.B., Mostashari F., and Kerker B.D. Use of pharmacy data to evaluate smoking regulations' impact on sales of nicotine replacement therapies in New York City. Am J Public Health 95 6 (2005) 1050-1055
30. Miller N., Frieden T.R., Liu S.Y., et al. Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet 365 9474 (2005) 1849-1854
31. Swartz S.H., Cowan T.M., Klayman J.E., Welton M.T., and Leonard B.A. Use and effectiveness of tobacco telephone counseling and nicotine therapy in Maine. Am J Prev Med 29 4 (2005) 288-294
32. Gilpin E.A., Pierce J.P., Johnson M., and Bal D. Physician advice to quit smoking: results from the 1990 California Tobacco Survey. J Gen Intern Med 8 10 (1993) 549-553
33. CDC. Guide to Community Preventive Services. Increasing tobacco use cessation (2009), CDC, Atlanta GA
34. Bondi M.A., Harris J.R., Atkins D., French M.E., and Umland B. Employer coverage of clinical preventive services in the U.S. Am J Health Promot 20 3 (2006) 214-222
35. National Business Group on Health. Exploring employers' understanding and perceptions of the business impact of smoking (2007). http://www.businessgrouphealth.org/tobacco/surveys/index.cfm Washington
36. McPhillips-Tangum C., Rehm B., Carreon R., Erceg C.M., and Bocchino C. Addressing tobacco in managed care: results of the 2003 survey. Prev Chronic Dis 3 3 (2006) A87
37. CDC. State Medicaid coverage for tobacco-dependence treatments-U.S., 2006. MMWR Morb Mortal Wkly Rep 57 5 (2008) 117-122
38. Burns M.E., Rosenberg M.A., and Fiore M.C. Use of a new comprehensive insurance benefit for smoking-cessation treatment. Prev Chronic Dis 2 4 (2005) A15
39. Boyle R.G., Solberg L.I., Magnan S., Davidson G., and Alesci N.L. Does insurance coverage for drug therapy affect smoking cessation?. Health Aff (Millwood) 21 6 (2002) 162-168
40. Alesci N.L., Boyle R.G., Davidson G., Solberg L.I., and Magnan S. Does a health plan effort to increase smokers' awareness of cessation medication coverage increase utilization and cessation?. Am J Health Promot 18 5 (2004) 366-369
41. McMenamin S.B., Halpin H.A., and Bellows N.M. Knowledge of Medicaid coverage and effectiveness of smoking treatments. Am J Prev Med 31 5 (2006) 369-374
42. Hopkins D.P., Briss P.A., Ricard C.J., et al. Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med 20 2S (2001) 16-66
43. Kaper J., Wagena E.J., Severens J.L., and Van Schayck C.P. Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database Syst Rev 1 (2005) CD004305
44. Schauffler H.H., McMenamin S., Olson K., Boyce-Smoth G., Rideout J.A., and Kamil J. Variations in treatment benefits influence smoking cessation: results of a randomized controlled trial. Tob Control 10 (2001) 175-180
45. Kaper J., Wagena E.J., Willemsen M.C., and van Schayck C.P. Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial. Addiction 100 7 (2005) 1012-1020
46. Cummins S.E., Bailey L., Campbell S., Koon-Kirby C., and Zhu S.H. Tobacco cessation quitlines in North America: a descriptive study. Tob Control 16 1S (2007) i9-i15
47. North American Quitline Consortium. North American quitlines: a profile of reach and services across the U.S. and Canada-2006 (2008), North American Quitline Consortium, Phoenix AZ
48. North American Quitline Consortium. U.S. telephone quitlines struggle to serve all callers spurred to quit by federal tax hike. www.naquitline.org/resource/resmgr/worldnotobaccoday_naqcpressr.pdf
49. http://www.usatoday.com/news/health/2009-04-02-smoking-hotlines_N.htm Accessed January 17, 2010
50. Farrelly M.C., Hussin A., and Bauer U.E. Effectiveness and cost effectiveness of television, radio and print advertisements in promoting the New York smokers' quitline. Tob Control 16 1S (2007) i21-i23
51. Cummings K.M., Fix B., Celestino P., Carlin-Menter S., O'Connor R., and Hyland A. Reach, efficacy, and cost effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract 12 1 (2006) 37-43
52. Cummings K.M., Hyland A., Fix B., et al. Free nicotine patch giveaway program 12-month follow-up of participants. Am J Prev Med 31 2 (2006) 181-184
53. Woods S.S., and Haskins A.E. Increasing reach of quitline services in a U.S. state with comprehensive tobacco treatment. Tob Control 16 1S (2007) i33-i36
54. Zhu S.H., Anderson C.M., Tedeschi G.J., et al. Evidence of real-world effectiveness of a telephone quitline for smokers. N Engl J Med 347 14 (2002) 1087-1093
55. Thorndike A.N., Rigotti N.A., Stafford R.S., and Singer D.E. National patterns in the treatment of smokers by physicians. JAMA 279 8 (1998) 604-608
56. Ferketich A.K., Khan Y., and Wewers M.E. Are physicians asking about tobacco use and assisting with cessation?. Results from the 2001-2004 national ambulatory medical care survey (NAMCS). Prev Med 43 6 (2006) 472-476
57. Quinn V.P., Stevens V.J., Hollis J.F., et al. Tobacco-cessation services and patient satisfaction in nine nonprofit HMOs. Am J Prev Med 29 2 (2005) 77-84
58. Casalino L., Gillies R.R., Shortell S.M., et al. External incentives, information technology, and organized processes to improve healthcare quality for patients with chronic diseases. JAMA 289 4 (2003) 434-441
59. Keller P.A., Fiore M.C., Curry S.J., and Orleans C.T. Systems change to improve health and health care: lessons from addressing tobacco in managed care. Nicotine Tob Res 7 1S (2005) S5-S8
60. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA 283 24 (2000) 3244-3254
61. Fiore M., Bailey W., Cohen S., et al. Smoking cessation: clinical practice guideline no. 18 (1996), USDHHS, Rockville MD AHCPR Publication No. 96-0692
62. Curry S.J., Keller P.A., Orleans C.T., and Fiore M.C. The role of healthcare systems in increased tobacco cessation. Annu Rev Public Health 29 (2008) 411-428
63. Orleans C.T., Woolf S.H., Rothemich S.F., Marks J.S., and Isham G.J. The top priority: building a better system for tobacco-cessation counseling. Am J Prev Med 31 1 (2006) 103-106
64. Kane R.L., Johnson P.E., Town R.J., and Butler M. Economic incentives for preventive care. Evid Rep Technol Assess (Summ) 101 (2004) 1-7
65. Andrews J.O., Tingen M.S., Waller J.L., and Harper R.J. Provider feedback improves adherence with AHCPR Smoking Cessation Guideline. Prev Med 33 5 (2001) 415-421
66. Roski J., Jeddeloh R., An L., et al. The impact of financial incentives and a patient registry on preventive care quality: increasing provider adherence to evidence-based smoking cessation practice guidelines. Prev Med 36 3 (2003) 291-299
67. Graham A.L., and Abrams D.B. Reducing the cancer burden of lifestyle factors: opportunities and challenges of the Internet. J Med Internet Res 7 3 (2005) e26
68. Fox S. Health information online (2005), Pew Internet and American Life Project, Washington
69. Cobb N.K., and Graham A.L. Characterizing Internet searchers of smoking cessation information. J Med Internet Res 8 3 (2006) e17
70. Cobb N.K., Graham A.L., Bock B.C., Papandonatos G., and Abrams D.B. Initial evaluation of a real-world Internet smoking cessation system. Nicotine Tob Res 7 2 (2005) 207-216
71. Swartz L.H., Noell J.W., Schroeder S.W., and Ary D.V. A randomised control study of a fully automated Internet-based smoking cessation programme. Tob Control 15 1 (2006) 7-12
72. Strecher V.J., Shiffman S., and West R. Randomized controlled trial of a web-based computer-tailored smoking cessation program as a supplement to nicotine patch therapy. Addiction 100 5 (2005) 682-688
73. Muñoz R.F., Lenert L.L., Delucchi K., et al. Toward evidence-based Internet interventions: a Spanish/English website for international smoking cessation trials. Nicotine Tob Res 8 1 (2006) 77-87
74. Walters S.T., Wright J.A., and Shegog R. A review of computer and Internet-based interventions for smoking behavior. Addict Behav 31 2 (2006) 264-277
75. Bock B., Graham A., Sciamanna C., et al. Smoking cessation treatment on the Internet: content, quality, and usability. Nicotine Tob Res 6 2 (2004) 207-219
76. Bock B.C., Graham A.L., Whiteley J.A., and Stoddard J.L. A review of web-assisted tobacco interventions (WATIs). J Med Internet Res 10 5 (2008) e39
77. Shiffman S. Reflections on smoking relapse research. Drug Alcohol Rev 25 1 (2006) 15-20
78. Hughes J.R., Keely J., and Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99 1 (2004) 29-38
79. Hughes J.R. Four beliefs that may impede progress in the treatment of smoking. Tob Control 8 3 (1999) 323-326
80. Abrams D.B., Orleans C.T., Niaura R.S., Goldstein M.G., Prochaska J.O., and Velicer W. Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: a combined stepped-care and matching model. Annals of Behavioral Medicine 18 4 (1996) 290-304
81. Fu S.S., Partin M.R., Snyder A., et al. Promoting repeat tobacco dependence treatment: are relapsed smokers interested?. Am J Manag Care 12 4 (2006) 235-243
82. Hall S.M., Humfleet G.L., Reus V.I., Munoz R.F., and Cullen J. Extended nortriptyline and psychological treatment for cigarette smoking. Am J Psychiatry 161 11 (2004) 2100-2107
83. Strecher V.J., Marcus A., Bishop K., et al. A randomized controlled trial of multiple tailored messages for smoking cessation among callers to the cancer information service. J Health Commun 10 1S (2005) S105-S118
84. Strecher V.J., Shiffman S., and West R. Moderators and mediators of a web-based computer-tailored smoking cessation program among nicotine patch users. Nicotine Tob Res 8 1S (2006) S95-S101
85. Shiffman S., Paty J.A., Rohay J., DiMarino M.E., and Gitchell J. The efficacy of computer-tailored smoking cessation material as a supplement to nicotine patch therapy. Drug and Alcohol Dependence 64 (2001) 35-46
86. Shiffman S., Paty J.A., Rohay J., DiMarino M.E., and Gitchell J. The efficacy of computer-tailored smoking cessation material as a supplement to nicotine polacrilex gum therapy. Arch Intern Med 160 11 (2000) 1675-1681
87. Velicer W.F., Prochaska J.O., and Redding C.A. Tailored communications for smoking cessation: past successes and future directions. Drug Alcohol Rev 25 1 (2006) 49-57
88. Barker D.C., Orleans C.T., and Schauffler H.H. Tobacco treatment services should be covered under Medicaid. Tob Control 7 1 (1998) 92
89. Lipkus I.M., Lyna P.R., and Rimer B.K. Using tailored interventions to enhance smoking cessation among African Americans at a community health center. Nicotine Tob Res 1 1 (1999) 77-85
90. Lancaster T., and Stead L.F. Self-help interventions for smoking cessation. Cochrane Database Syst Rev 3 (2005) CD001118
91. Bentz C.J., Bayley K.B., Bonin K.E., Fleming L., Hollis J.F., and McAfee T. The feasibility of connecting physician offices to a state-level tobacco quitline. Am J Prev Med 30 1 (2006) 31-37
92. Lawrence D., Graber J.E., Mills S.L., Meissner H.I., and Warnecke R. Smoking cessation interventions in U.S. racial/ethnic minority populations: an assessment of the literature. Prev Med 36 2 (2003) 204-216
93. Kreuter M.W., and McClure S.M. The role of culture in health communication. Annu Rev Public Health 25 (2004) 439-455
94. Nollen N., Ahluwalia J.S., Mayo M.S., et al. A randomized trial of targeted educational materials for smoking cessation in African Americans using transdermal nicotine. Health Educ Behav 34 6 (2007) 911-927
95. Epstein J. Why Model? Paper presented at: Second World Congress on Social Simulation; 2008; George Mason University.
96. Mabry P.L., Olster D.H., Morgan G.D., and Abrams D.B. Interdisciplinarity and systems science to improve population health: a view from the NIH Office of Behavioral and Social Sciences Research. Am J Prev Med 35 S2 (2008) S211-S224
97. Sterman J.D. Learning from evidence in a complex world. Am J Public Health 96 3 (2006) 505-514